Video·3 min read·May 2026

The Science of Cold and Warm: How Contrast Therapy Can Enhance Your Resilience

Cold Therapy|Mechanisms • 3 min read • Based on research by Akihito Uehara, Sei-ichiro Motegi, Kazuya Yamada, Akihiko Uchiyama, Buddhini Perera, Sayaka Toki, Sachiko Ogino, Yoko Yokoyama, Yuko Takeuchi, Osamu Ishikawa (2016)

Imagine stepping into a sanctuary where your body is revitalized and your mind finds clarity. This is the essence of contrast therapy—a practice that alternates between heat and cold, inviting your body to embrace resilience and recovery. But how does this ancient ritual align with modern science?

Recent research offers fascinating insights into the role of norepinephrine, a neurotransmitter that plays a pivotal part in our body's response to stress and temperature changes. Understanding this mechanism not only deepens our appreciation for contrast therapy but also opens new avenues for managing conditions like systemic sclerosis. Let’s explore these insights together.

Norepinephrine: The Body’s Stress Messenger

Norepinephrine (NE) is released by our sympathetic nervous system during moments of cold exposure or emotional stress. This neurotransmitter acts as a messenger, influencing various bodily functions. In the context of systemic sclerosis (SSc), a condition characterized by skin and organ fibrosis, NE has a particularly significant impact.

The research found that NE enhances the production of interleukin-6 (IL-6) in fibroblasts from patients with SSc, which is notably higher than in normal fibroblasts. IL-6 is a cytokine that stimulates collagen production, leading to the thickening of skin and other tissues. This means that when NE levels rise, as they do during cold exposure, it can contribute to the worsening of skin fibrosis in SSc patients.

The Connection Between Cold Exposure and Fibrosis

Cold exposure triggers an increase in norepinephrine, which, in turn, elevates IL-6 levels. This connection is crucial for understanding how our bodies respond to temperature variations. The study highlighted that when fibroblasts from SSc patients were stimulated with 10 μM of NE, a significant increase in IL-6 production was observed, particularly after one hour.

This finding suggests that while cold therapy can be beneficial for many, it may also inadvertently exacerbate conditions like SSc if not approached mindfully. Understanding this mechanism invites us to consider the nuances of our wellness rituals, allowing us to harness the benefits of cold exposure while remaining aware of its potential impacts.

Harnessing the Power of Contrast Therapy

So, what does this mean for those of us looking to integrate contrast therapy into our wellness routines? The research underscores the importance of being intentional about our protocols. While cold exposure can stimulate resilience and recovery, it is essential to balance it with warmth, which can promote relaxation and healing.

For individuals managing conditions influenced by IL-6, such as SSc, it might be beneficial to incorporate warm therapies alongside cold exposure. This balanced approach can help mitigate the potential overproduction of IL-6 while still reaping the benefits of contrast therapy.

Key Takeaways

Norepinephrine plays a crucial role in the body's response to cold and stress, impacting conditions like systemic sclerosis.
Cold exposure can increase IL-6 production, which may worsen fibrosis; a balanced approach with warmth can help manage this risk.
Integrating contrast therapy mindfully allows you to harness its benefits while considering your unique health needs.

Based on: Mechanistic insight into the norepinephrine-induced fibrosis in systemic sclerosis
Akihito Uehara, Sei-ichiro Motegi, Kazuya Yamada, Akihiko Uchiyama, Buddhini Perera, Sayaka Toki, Sachiko Ogino, Yoko Yokoyama, Yuko Takeuchi, Osamu Ishikawa (2016). Scientific Reports

Contrast Collective • Science-backed wellness

Wim's Wise Words

A second take, from someone who's lived it.

🧊 Wim's Wise Words

Mechanistic insight into the norepinephrine-induced fibrosis in systemic

The Core Claim

This paper makes a specific, uncomfortable argument: for people with systemic sclerosis, cold exposure and emotional stress don't just trigger Raynaud's vasospasms — they may actively accelerate skin fibrosis. The mechanism runs through norepinephrine. When NE levels rise in response to cold or stress, it binds to beta-adrenergic receptors on skin fibroblasts, activates a signaling protein called p38, and drives up IL-6 production. IL-6 then stimulates collagen overproduction. That cascade — NE → ARβ → p38 → IL-6 → collagen — is the molecular story of why SSc patients get worse in the cold.

The research team at Gunma University didn't just describe the effect. They mapped the pathway with precision, blocking it at multiple points to confirm causation. That methodological rigor matters. This isn't correlation. It's mechanism.

How This Compares

We already knew IL-6 was elevated in SSc patients, and we knew it correlated with skin thickness scores. What this paper adds is the upstream trigger: norepinephrine, the very neurotransmitter that floods your system during a cold plunge. The connection between sympathetic nervous system activation and autoimmune progression isn't new territory — chronic stress has long been implicated in inflammatory disease flares — but seeing the molecular handshake drawn this precisely is sobering.

It also reframes something I find in the broader cold exposure literature. Most of that research focuses on healthy subjects. Huberman's work on norepinephrine, for instance, emphasizes its role in sharpening focus, boosting mood, and priming the immune system. All of that is true — for people without underlying connective tissue disorders. The Uehara study reminds us that biology is context-dependent. The same neurotransmitter that builds resilience in one person may amplify pathology in another.

The same cold that builds resilience in a healthy body may be adding fuel to a fire that's already burning in an SSc patient. Norepinephrine doesn't know the difference. It just does its job.

Where the Research Gets Interesting

Here's the nuance that most summaries of this paper miss: norepinephrine activates two competing receptor pathways. The beta-adrenergic route (ARβ → p38) drives IL-6 up. But the alpha-adrenergic route (ARα → ERK1/2) actually pushes back — it inhibits IL-6 production. These two signals exist simultaneously. The net outcome depends on which pathway dominates, and in SSc fibroblasts, the beta pathway wins. That's the vulnerability. It also hints at a therapeutic angle: propranolol, a beta-blocker that's been around for decades, blocked NE-induced IL-6 production in the lab. Whether that translates clinically in SSc is still being investigated, but it's a thread worth watching.

The Practical Recommendation

If you have systemic sclerosis, or are working with someone who does, cold therapy requires a different conversation. The protocols that work beautifully for recovery, mood, and metabolic health in healthy individuals may not apply — and this paper suggests a plausible biological reason why. That doesn't mean cold exposure is categorically off the table, but it should be approached with a rheumatologist in the loop, not from a wellness blog.

For everyone else, this research is a useful reminder that wellness protocols are not universal medicines. Dose, duration, timing, and individual biology all shape the outcome. Cold is a tool. Like any tool, knowing when not to use it is part of mastering it.

The Surprising Connection

Endothelin-1 — a vasoconstrictor already implicated in SSc pathology — was tested alongside NE in this study. The result was additive. More NE plus more endothelin-1 equals significantly more IL-6 than either stimulus alone. SSc patients already have elevated endothelin-1 at baseline. So when cold exposure spikes their NE, it doesn't land in a neutral biochemical environment. It lands on kindling. That's the kind of systems-level insight that changes how you think about stress, environment, and chronic disease — not as isolated variables, but as overlapping signals that compound in ways the body can't always dampen.

Mechanistic insight into the norepinephrine-induced fibrosis in systemic

The Science of Cold and Warm: How Contrast Therapy Can Enhance Your Resilience

Norepinephrine: The Body’s Stress Messenger

The Connection Between Cold Exposure and Fibrosis

Harnessing the Power of Contrast Therapy

Key Takeaways

Related articles

The potential role of fibroblast growth factor 21 in lipid metabolism

Harnessing the Power of Cold Exposure for Enhanced Well-Being

The Healing Power of Contrast Therapy: Evidence-Based Protocols for Recovery